Meanwhile, the clinical research data from BC patients revealed yet again that patients with a low survival rate and poor prognosis usually have increased Nrf2 gene activity which promotes tumor cell proliferation, invasion and migration [17]. Here, NFE2L2 is linked to neoplasm.